Geron
GERN
#7211
Rank
โ‚น51.98 B
Marketcap
โ‚น80.69
Share price
-4.63%
Change (1 day)
-15.76%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -โ‚น1.7 Billion

According to Geron's latest financial reports the company's current earnings are โ‚น0.21 Billion. In 2025 the company made an earning of -โ‚น4.72 Billion, an increase over its 2024 earnings that were of -โ‚น14.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น1.7 Billion-64.08%
2025 -โ‚น4.72 Billion-67.42%
2024 -โ‚น14.47 Billion-11.23%
2023 -โ‚น16.3 Billion30.22%
2022 -โ‚น12.52 Billion20.15%
2021 -โ‚น10.42 Billion50.08%
2020 -โ‚น6.94 Billion4.46%
2019 -โ‚น6.65 Billion130.68%
2018 -โ‚น2.88 Billion8.84%
2017 -โ‚น2.65 Billion-3.08%
2016 -โ‚น2.73 Billion-22080.6%
2015 โ‚น12.41 M-100.38%
2014 -โ‚น3.3 Billion-7.14%
2013 -โ‚น3.56 Billion
2011 -โ‚น8.41 Billion19.04%
2010 -โ‚น7.06 Billion8.45%
2009 -โ‚น6.51 Billion-2.51%
2008 -โ‚น6.68 Billion14.65%
2007 -โ‚น5.83 Billion32.68%
2006 -โ‚น4.39 Billion25.59%
2005 -โ‚น3.5 Billion4.36%
2004 -โ‚น3.35 Billion19.73%
2003 -โ‚น2.8 Billion-15.46%
2002 -โ‚น3.31 Billion1.94%
2001 -โ‚น3.25 Billion33.59%
2000 -โ‚น2.43 Billion27.53%
1999 -โ‚น1.91 Billion63.13%
1998 -โ‚น1.17 Billion15.6%
1997 -โ‚น1.02 Billion-10.66%
1996 -โ‚น1.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-โ‚น234.74 Billion 13,205.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น73.78 B-4,282.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น6.42 Billion 263.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น23.19 B-1,414.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1.54 Billion-13.22%๐Ÿ‡บ๐Ÿ‡ธ USA